These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11287680)

  • 1. A central core structure in an antibody variable domain determines antigen specificity.
    Jirholt P; Strandberg L; Jansson B; Krambovitis E; Söderlind E; Borrebaeck CA; Carlsson R; Danielsson L; Ohlin M
    Protein Eng; 2001 Jan; 14(1):67-74. PubMed ID: 11287680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry of human tumor antigen by heavy chain CDR3 sequence of the anti-idiotypic antibody.
    Luo D; Qi W; Ma J; Wang YJ; Wishart D
    J Biochem; 2000 Sep; 128(3):345-7. PubMed ID: 10965030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
    Barrios Y; Jirholt P; Ohlin M
    J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of murine monoclonal antibodies through variable domain resurfacing.
    Roguska MA; Pedersen JT; Keddy CA; Henry AH; Searle SJ; Lambert JM; Goldmacher VS; Blättler WA; Rees AR; Guild BC
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):969-73. PubMed ID: 8302875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
    Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody.
    Shanehbandi D; Majidi J; Kazemi T; Baradaran B; Aghebati-Maleki L
    Hum Antibodies; 2017; 26(1):1-6. PubMed ID: 28269762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of human germline genes in a CDR homology-based approach to antibody humanization.
    Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
    Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies.
    van der Donk EM; Schutten M; Osterhaus AD; van der Heijden RW
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1639-49. PubMed ID: 7888223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary structure of the variable regions of a monoclonal antibody MUSE11 recognizing the tandem repeat domain of a mucin core protein, MUC1.
    Hinoda Y; Arimura Y; Itoh F; Adachi M; Tsujisaki M; Imai K; Yachi A
    J Clin Lab Anal; 1993; 7(2):100-4. PubMed ID: 7685048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition.
    Dondelinger M; Filée P; Sauvage E; Quinting B; Muyldermans S; Galleni M; Vandevenne MS
    Front Immunol; 2018; 9():2278. PubMed ID: 30386328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
    Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
    Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetic analysis of variable regions encoding AB1 and gamma-type AB2 antibodies from the NeuGc-containing ganglioside family.
    Perez A; Lombardero J; Mateo C; Mustelier G; Alfonso M; Vazquez AM; Perez R
    Hybridoma; 2001 Aug; 20(4):211-21. PubMed ID: 11604106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a peptide mimotope to guide the humanization of MRK-16, an anti-P-glycoprotein monoclonal antibody.
    Tang Y; Beuerlein G; Pecht G; Chilton T; Huse WD; Watkins JD
    J Biol Chem; 1999 Sep; 274(39):27371-8. PubMed ID: 10488067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.
    Shlomchik MJ; Nemazee DA; Sato VL; Van Snick J; Carson DA; Weigert MG
    J Exp Med; 1986 Aug; 164(2):407-27. PubMed ID: 3088205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.